Healthy volunteers

98 total trials 16 recruiting

Filter these 98 trials by phase, country, sponsor and more.

Open in Search →

A study to investigate the pharmacokinetics and safety of a single dose of duvakitug in healthy adult participants Recruitment ended

2025-524617-84-00 3 2026-04-09
The effect of losartan on cephalexin Recruitment ended

2025-525059-23-00 3 2026-03-04
A trial to learn how well different doses of andexanet alfa work and how they affect blood clotting throughout the body in healthy adults wh … Recruitment ended

2025-522513-30-00 3 2026-01-12
Phase I study to evaluate safety and immunogenicity of V-212 in healthy adult volunteers. Recruitment ended

2024-516008-41-00 1 2025-01-29
ANRS0407s -LKV.Cov40. A phase 1/2 multicenter, randomized study of the safety and immunogenicity of a sub-unit protein CD40.RBDv bivalent CO … Recruitment ended

2023-504594-20-00 1 2025-01-06
Morphine effects on stress response and social interaction – an exploratory randomized controlled experimental medicine study Recruitment ended

2024-517855-10-00 4 2022-04-20
Evaluation of tolerance and pharmacokinetics profile of high dose favipiravir in healthy volunteers - FAVIDOSE Halted

2022-502871-49-00 3 2024-04-05
A Phase 1, Double-blind, Randomized, Three-arm, Parallel Group Study to Compare the Pharmacokinetics and Safety of a Single Subcutaneous Dos … Halted

2024-519145-30-00 3 2022-03-31
OPEN-LABEL PALATABILITY STUDY OF A NOVEL ORODISPERSIBLE PARACETAMOL/IBUPROFEN FORMULATION AFTER A SINGLE ORAL ADMINISTRATION IN HEALTHY SUBJ … Ended

2025-524274-41-00 3 2026-01-26
Bioequivalence clinical trial of two formulations of loperamide. Ended

2025-523705-14-00 2 2025-10-23
Bioequivalence clinical trial of two formulations of linagliptin Ended

2025-523384-37-00 2 2025-10-10
RANDOMIZED, CROSSOVER, TWO-PERIOD, COMPARATIVE BIOAVAILABILITY STUDY OF TWO IBUPROFEN FORMULATIONS, AFTER A SINGLE ORAL DOSE OF 400 MG IN SO … Ended

2025-520852-27-00 3 2025-09-18
Randomized, open-label, three-period crossover study on the palatability of oral dispersible formulations of Zonisamide in healthy volunteer … Ended

2025-522297-36-00 3 2025-09-03
Bioequivalence clinical trial of two formulations of dapagliflozin/metformin Ended

2024-510791-20-00 2 2025-08-29
Jim Beam Cumulative Irritation Patch Test Ended

2025-520663-41-00 1 2025-07-21
Bioequivalence clinical trial of two formulations of loperamide. Ended

2025-521549-26-00 2 2025-07-02
Randomised, crossover bioequivalence clinical trial of edoxaban 60 mg tablets versus edoxaban 60 mg film-coated tablets, after a single oral … Ended

2025-522225-35-00 2 2025-06-23
A study to assess the safety of ARGX-121 in Healthy Adult Participants Ended

2025-521524-30-00 1 2025-06-05
Bioequivalence clinical trial of two formulations of dapagliflozin/metformin Ended

2024-514050-75-01 2 2025-06-04
A Study on Oral and Intranasal Forms in Healthy Volunteers using Pharmacokinetic Modeling Ended

2024-515461-34-00 3 2025-05-14
Phase 1 clinical trial to evaluate the safety, tolerability and pharmacokinetics of multiple daily doses of IM-250 in healthy volunteers. Ended

2024-519482-22-00 3 2025-04-30
Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants Ended

2025-520840-14-00 3 2025-04-29
Phase I clinical trial to evaluate the pharmacokinetics, safety and tolerability of repeated topical application of PARENTIDE in healthy vol … Ended

2024-516833-11-00 3 2025-03-12
Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults. Ended

2024-515285-14-00 1 2025-03-04

Showing 25–48 of 98 trials